Skip to content Skip to left sidebar Skip to footer

Author: Rishi Sharma

Monkeypox Vaccine Update: Expanded Eligibility & Second Doses

Monkeypox Vaccine Update: Expanded Eligibility & Second Doses

There is now vaccine supply to begin administering a complete two-dose Jynneos vaccine series to each individual who is eligible for vaccine.

Updates

Eligibility for a first dose now includes:
• People of all ages. Subcutaneous administration continues to be required for those <18.
• People with a history of STI in the past 12 months, as well as individuals who plan to have multiple or anonymous sex partners, or those plan to meet new sexual partners via social media.

Eligibility for a second dose now includes:
• People who have received a first Jynneos vaccine dose through either intradermal or subcutaneous administration. This dose should be given intradermally to those 18 and older unless there is a contraindication.

Eligibility has also expanded to include those with a history of STI in the past 12 months (from 6 months previously) and to start offering preexposure prophylaxis to people at high risk for becoming infected. The interval between doses for both subcutaneous and intradermal injections is at minimum 28 days. Individuals who test positive for monkeypox after their first dose should not receive a second dose of vaccine. Individuals whose second doses have been delayed do not need to restart the two-dose vaccine series.

There is no age requirement for Jynneos vaccine eligibility, although those less than 18 years of age must receive the vaccine subcutaneously. Individuals 18 and older will be given intradermal vaccination, regardless of which method was used for the first vaccine, unless there is a contraindication.

Complete eligibility criteria include:

People who meet the following condition:

• Gay, bisexual, transgender, non-binary, and other men who have sex with men, transgender, or non-binary persons

AND meet ONE of the following criteria:

• Have had multiple or anonymous sex partners in the last 14 days
• Have had any newly diagnosed STI in the past 12 months, including gonorrhea, chlamydia, early syphilis, or HIV
• Have recently attended or plan to attend any venue where anonymous sex or sex with multiple partners will occur (e.g. saunas, bathhouses, sex clubs, sex parties) in the next 30 days
• Have met recent partners or plan to meet new partners in the next 30 days through social media platforms (such as Grindr, Tinder or Scruff), or at clubs, raves, sex parties, saunas

Additionally, the following people are eligible:

• Sex workers (of any sex or gender), and/or
• Anyone with known close contact (skin-to-skin) with someone with monkeypox in the past 14 days

When using an intradermal strategy, there may be unused doses in a single vial. All efforts should be made to give doses to the above eligible individuals. If there are doses that would go wasted, they may be given to other individuals not included in the above criteria. Healthcare workers directly involved in testing and examining those with possible monkeypox illness and staff involved in environmental cleaning and disinfection protocols should be prioritized.

Thank you for keeping Philadelphia safe and healthy! If you have any questions about these updates, please contact vaccines@phila.gov.

Aetna Better Health Medicaid Coverage Discontinued

Aetna Better Health Medicaid Coverage Discontinued

Aetna Better Health of Pennsylvania (ABH-PA) Medicaid Coverage was Discontinued Wednesday, August 31st, 2022. As of Thursday, September 1, 2022, patients with this plan will no longer be covered by this plan. Letters were sent to ABH-PA plan members to help them with the transition. They can also call the phone number on the back of their card for more information.

As a provider, please:

  • Continue to vaccinate these patients. They are still VFC and medicaid eligible.
  • Do not charge patients out of pocket for care or vaccine administration. 
  • Support patients identify, or as they identify, a new provider if their new Medicaid plan is out of network. Email our team at vaccines@phila.gov with any questions.

These changes do not affect the Aetna Better Health of Pennsylvania Kids Children’s Health Insurance Program (CHIP). Aetna Better Health CHIP will remain in place following the changes to their Medicaid program. 

Questions?

You can direct questions regarding the closure of ABH-PA to their dedicated mailbox at PAMedicaidClosureProviderRelationsMailbox@AETNA.com. 

Other questions can be directed to vaccines@phila.gov. Thank you for keeping Philadelphia safe and healthy!

Invitation to Discuss Monkeypox Testing, Treatment, and Vaccine

Invitation to Discuss Monkeypox Testing, Treatment, and Vaccine

FQHC Partners,

On Wednesday, August 17, PDPH is inviting you to participate in a discussion about monkeypox testing, treatment, and vaccine. Please mark your calendars, and join using the meeting information below!

PDPH is inviting you to a scheduled Zoom meeting.
Topic: FQHC Discussion on monkeypox testing, treatment, and vaccine
Time: Aug 17, 2022 12:00 PM Eastern Time (US and Canada)

Join Zoom Meeting
https://us06web.zoom.us/j/81516780822

Meeting ID: 815 1678 0822

One tap mobile
+16465588656,,81516780822# US (New York)
+16469313860,,81516780822# US

Dial by your location

+1 646 558 8656 US (New York)
+1 646 931 3860 US
+1 301 715 8592 US (Washington DC)
+1 309 205 3325 US
+1 312 626 6799 US (Chicago)
+1 719 359 4580 US
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)
+1 386 347 5053 US
+1 564 217 2000 US
+1 669 444 9171 US
+1 669 900 6833 US (San Jose)

Meeting ID: 815 1678 0822

Find your local number: https://us06web.zoom.us/u/kcXvdHapmW

Thank you for your dedication to keeping Philadelphians safe and healthy.

Updated Eligibility Criteria for Monkeypox Vaccine

Updated Eligibility Criteria for Monkeypox Vaccine

There has been a recent update in eligibility criteria for monkeypox vaccination, including sex workers of any sex or gender, as well as anyone who has had recent close contact with someone infected with monkeypox.Eligible individuals include:
  • Gay, bisexual, transgender, non-binary, and other men who have sex with men, transgender, or non-binary persons, who are 18 years of age or older.
    • And have had multiple or anonymous sex partners in the last 14 days, and/or believe they have been exposed to an STI within the last 14 days.
    • Or have had any newly diagnosed STI in the past 6 months*, including gonorrhea, chlamydia, early syphilis, or HIV.
  • Sex workers of any sex or gender.
  • Anyone with known close, skin-to-skin contact within the last 14 days with someone infected with monkeypox.
*Eligibility criteria has been modified from a newly diagnosed STI in the past 3 months to the past 6 months.
Thank you for your dedication to curbing the spread of monkeypox. If you have any questions about these criteria, please reach out to vaccines@phila.gov.

Contact the Immunization Program!

Contact the Immunization Program!

The Immunization Program manages several email accounts to support providers and the public with immunization-related queries. Use this guide to determine who to contact based on the nature of your request:

PhilaVax@phila.gov: PhilaVax account support and technical issues (patient update requests, vaccine reporting questions, etc.)

Vaccines@phila.gov: General inquiries.

DPHProviderHelp@phila.gov: Medical provider assistance (Clinic Tools and inventory support, vaccine ordering and returns, reconciliation, staff changes, etc.)

TempCheck@phila.gov: Vaccine storage and handling inquiries (temperature logs, storage units, DDL technical problems, etc.)

Covidproviders@phila.gov: Adult COVID-19 provider questions and Bridge Access Program questions.

Prefer calling?

The following telephone and fax numbers are available for providers as well:

Storage and Handling
p 215.685.6777
f 215.238.6948

VFC & VFAAR
p 215.685.6728
f 215.238.6948

Thank you for keeping Philadelphia safe and healthy!

Recommend HPV Vaccine at Every Visit!

Recommend HPV Vaccine at Every Visit!

During the first year of the COVID-19 pandemic, there was a decrease in HPV doses administered in the United States.

Here in Philadelphia, there was a 29% decrease in the total number of HPV doses administered in 2020 compared to 2019. This decrease affected every eligible age group:

  • 9-13 year olds: HPV doses administered decreased by 17.5% from 2019 to 2020.
  • 13-17 year olds: HPV doses administered decreased by 41.7% from 2019 to 2020.
  • 18-26 year olds: HPV doses administered decreased by 53.7% from 2019 to 2020.

March 4 is International HPV Awareness Day!

To help bring HPV vaccination rates back to pre-pandemic levels, recommend HPV vaccine at every visit for 9-26 year olds who have not begun or completed their series. 

Register for this CME webinar on March 2 from 1-2pm EST! Dr. Danielle Casher (Attending Physician, Children’s Hospital of Philadelphia) will join cancer survivor Megan Lesar to discuss improving HPV vaccine rates in Pennsylvania.

On March 4, watch and share this video from the Association of Immunization Managers (AIM) to promote timely, complete HPV vaccination.

Steps to Recommend HPV Vaccine to Hesitant Parents

Announce: 

  • Your child is __ years old.
  • Today, they are eligible to receive Tdap, HPV, and MCV vaccine.
  • We will make sure they get all these shots to keep them safe and healthy.

If parent hesitates:

Connect and Counsel:

  • What’s your main concern?
  • Counsel using a research-tested method (ex.”Over 30,000 Americans get cancer from HPV every year. Most could be prevented with the HPV vaccine.”)

If parent declines:

Try Again: 

  • Almost 70% of parents who initially declined later agree to HPV vaccine or plan to vaccinate soon.

Resources

Print:

Online:

Have questions? Reach out to our team at vaccines@phila.gov. Thank you for all that you do to keep Philadelphia safe and healthy!